title: Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer.
authors: Cheng-Jui
authors: CJ
authors: Lin
authors: Ruey-Kuen
authors: RK
authors: Hsieh
authors: Ken-Hong
authors: KH
authors: Lim
authors: Han-Hsiang
authors: HH
authors: Chen
authors: Yi-Chou
authors: YC
authors: Cheng
authors: Chih-Jen
authors: CJ
authors: Wu
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary*; D017809:Fatal Outcome; D005485:Flutamide / Q000008:administration & dosage; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D005485:Flutamide; D016729:Leuprolide